Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 + 433 word(s) 433 2020-12-15 08:01:50

Video Upload Options

Do you have a full video?


Are you sure to Delete?
If you have any further questions, please contact Encyclopedia Editorial Office.
Guo, L. MVK Gene. Encyclopedia. Available online: (accessed on 19 April 2024).
Guo L. MVK Gene. Encyclopedia. Available at: Accessed April 19, 2024.
Guo, Lily. "MVK Gene" Encyclopedia, (accessed April 19, 2024).
Guo, L. (2020, December 23). MVK Gene. In Encyclopedia.
Guo, Lily. "MVK Gene." Encyclopedia. Web. 23 December, 2020.
MVK Gene

mevalonate kinase


1. Introduction

The MVK gene provides instructions for making the mevalonate kinase enzyme. This enzyme converts a substance called mevalonic acid into mevalonate-5-phosphate. This conversion is the second step in a pathway that produces cholesterol. The cholesterol is later converted into steroid hormones and bile acids. Steroid hormones are needed for normal development and reproduction, and bile acids are used to digest fats. Mevalonate kinase also helps to produce other substances that are necessary for certain cellular functions, such as cell growth, cell maturation (differentiation), formation of the cell's structural framework (the cytoskeleton), gene activity (expression), and protein production and modification.

2. Health Conditions Related to Genetic Changes

2.1. Mevalonate kinase deficiency

At least 80 mutations in the MVK gene have been found to cause mevalonate kinase deficiency. There are two types of mevalonate kinase deficiency, which are differentiated by the severity of the signs and symptoms. The less severe of the two types is called hyperimmunoglobulinemia D syndrome (HIDS) and the more severe type is called mevalonic aciduria (MVA). Most of the MVK gene mutations that cause mevalonate kinase deficiency lead to changes in single protein building blocks (amino acids) in the mevalonate kinase enzyme. One mutation that replaces the amino acid valine with the amino acid isoleucine at position 337 in the enzyme (written as Val337Ile or V337I) is found in approximately 80 percent of people with HIDS. The V337I mutation has never been found in people with MVA.

Most MVK gene mutations lead to the production of a mevalonate kinase enzyme that is unstable and folded into an incorrect 3-dimensional shape, leading to a reduction of mevalonate kinase enzyme activity. The severity of the enzyme shortage (deficiency) determines the severity of the condition. People who have approximately 1 to 20 percent of normal mevalonate kinase activity typically develop HIDS. Individuals who have less than 1 percent of normal enzyme activity usually develop MVA. Despite this shortage of mevalonate kinase activity, people with mevalonate kinase deficiency typically have normal production of cholesterol, steroid hormones, and bile acids.

Some researchers believe the features may be due to a buildup of mevalonic acid, the substance that mevalonate kinase normally acts on. Other researchers think that a shortage of the substances produced from mevalonic acid, such as those substances necessary for certain cellular functions, causes the fever episodes and other features of this condition. The exact mechanism that causes inflammatory reactions such as fevers, skin rashes, elevated immune system proteins, and many other features of mevalonate kinase deficiency is unclear.

3. Other Names for This Gene


  • LH receptor mRNA-binding protein

  • LRBP

  • mevalonate kinase 1

  • MK

  • MVLK


  1. Buhaescu I, Izzedine H. Mevalonate pathway: a review of clinical andtherapeutical implications. Clin Biochem. 2007 Jun;40(9-10):575-84.
  2. Haas D, Hoffmann GF. Mevalonate kinase deficiencies: from mevalonic aciduriato hyperimmunoglobulinemia D syndrome. Orphanet J Rare Dis. 2006 Apr 26;1:13.Review.
  3. Mandey SH, Schneiders MS, Koster J, Waterham HR. Mutational spectrum andgenotype-phenotype correlations in mevalonate kinase deficiency. Hum Mutat. 2006 Aug;27(8):796-802.
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to :
View Times: 255
Entry Collection: MedlinePlus
Revision: 1 time (View History)
Update Date: 23 Dec 2020